Rodger D. Kempsford

Middlesex, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma.

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma.

Journal: Pediatric pulmonology

Published: December 21, 2018

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.

Journal: Respiratory research

Published: April 26, 2018

Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.

Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.

Journal: Respiratory medicine

Published: February 18, 2016

The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.

The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.

Journal: Respiratory medicine

Published: September 02, 2015

Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.

Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.

Journal: Pharmacotherapy

Published: June 11, 2015

Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.

Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.

Journal: Clinical therapeutics

Published: November 21, 2013

The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.

The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.

Journal: Clinical pharmacology in drug development

Published: October 08, 2013

The safety, pharmacokinetics and pharmacodynamics of a combination of fluticasone furoate and vilanterol in healthy Japanese subjects.

The safety, pharmacokinetics and pharmacodynamics of a combination of fluticasone furoate and vilanterol in healthy Japanese subjects.

Journal: International journal of clinical pharmacology and therapeutics

Published: June 06, 2013

The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.

The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.

Journal: Respiratory medicine

Published: March 22, 2013

Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.

Journal: Clinical pharmacology in drug development

Published: February 21, 2013

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

Journal: Clinical pharmacology in drug development

Published: December 18, 2012

A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects.

A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects.

Journal: British journal of clinical pharmacology

Published: November 29, 2012

Showing 1-12 of 18

Last Updated: 09/26/2026